Wealth Enhancement Trust Services’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2
Closed -$4 – 1088
2026
Q2
$4 Buy
+2
New +$3 ﹤0.01% 1525

Other funds holding HCAT

Wealth Enhancement Trust Services's HCAT Position: Q3 2026 in Review

Wealth Enhancement Trust Services sold out of Health Catalyst (HCAT) in Q3 2026, closing a stake of 2 shares — an estimated $4 sold.

Wealth Enhancement Trust Services first reported a position in HCAT in Q2 2026 and held it in 1 quarter. The position peaked at $4 in Q2 2026. 76 funds tracked by Wall St. Rank hold HCAT as of Q3 2026.

  • Wealth Enhancement Trust Services reported no remaining Health Catalyst position as of Q3 2026 after selling out during the quarter.
  • Wealth Enhancement Trust Services sold 2 Health Catalyst shares in Q3 2026, an estimated $4.
  • Wealth Enhancement Trust Services first reported a position in Health Catalyst in Q2 2026 and held it in 1 quarter.
  • Wealth Enhancement Trust Services's Health Catalyst position peaked at $4 in Q2 2026.
  • 76 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q3 2026, filed 7 Oct 2026.